Does Oxycodone Cause Constipation?

Oxycodone reliably causes constipation in a large share of people who take it, and the effect can begin within the first few days of use. This is not a rare side effect or an unlucky reaction; it is a direct, predictable consequence of how opioids interact with the gut’s own nervous system. What surprises many people is that unlike drowsiness or nausea, the constipation does not fade with continued use.

Why Oxycodone Slows the Gut

Your digestive tract has its own dense network of nerve cells, sometimes called the “second brain,” and those neurons are studded with opioid receptors. When oxycodone enters the bloodstream, it binds to mu-opioid receptors throughout the gastrointestinal tract. That binding reduces the release of chemical signals that normally keep your intestines contracting in coordinated waves, pushing food and waste along. The result is that everything slows down: the stomach empties more slowly, the small intestine absorbs more water from its contents, and the colon’s squeezing motions lose their rhythm.1PubMed Central. Molecular physiology of enteric opioid receptors

On top of the slowdown in motility, oxycodone also affects the muscles at the very end of the digestive tract. Research has shown that opioid treatment reduces the normal relaxation of the anal sphincter, making it physically harder to pass stool even once you feel the urge.2Scandinavian Journal of Pain. Oxycodone and macrogol 3350 treatment reduces anal sphincter relaxation compared to combined oxycodone and naloxone tablets So the problem is not simply that stool moves through more slowly; the exit mechanism itself becomes less cooperative.

More Than Just Constipation

Doctors increasingly use the term “opioid-induced bowel dysfunction” rather than just “constipation” because the effects go well beyond infrequent bowel movements. People taking oxycodone commonly experience bloating, abdominal pain, nausea, a sensation of incomplete emptying after using the bathroom, and general discomfort.3PubMed Central. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction In a study of healthy volunteers given oxycodone, bowel function scores worsened dramatically: constipation symptom scores nearly tripled, stools became harder and drier, and the volume of material sitting in the colon’s early segments increased substantially.4European Journal of Gastroenterology & Hepatology. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI The takeaway is that even if you are still having some bowel movements, oxycodone can make the entire digestive experience noticeably worse.

These symptoms can become severe enough that some people cut back on their pain medication or stop it altogether, choosing to endure more pain rather than deal with the gut problems.5PubMed Central. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction That is a real clinical problem: the medication that is supposed to improve your quality of life by controlling pain ends up degrading it in a different way.

It Does Not Get Better With Time

This is one of the most frustrating aspects of the problem. With many opioid side effects, your body gradually adjusts. Nausea tends to taper off after the first week or so, and drowsiness often eases as you settle into a stable dose. Constipation is different. Tolerance does not develop to the gut-slowing effects of opioids, which means the constipation persists for as long as you keep taking the drug.6PubMed Central. Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence If you are on oxycodone for months or years, you will likely need to manage the constipation for that entire duration.

How Common Is It

Estimates of constipation rates in opioid users vary depending on how the studies are designed and how strictly constipation is defined, but the range commonly cited in the literature is roughly 40 to 80 percent of people taking opioids.7PubMed Central. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety Individual studies using insurance claims data tend to report lower crude numbers because they rely on billing codes rather than patient-reported symptoms, and many people never bring up constipation with their doctor. One claims-based study found crude constipation rates of about 6 percent for controlled-release oxycodone, but after adjusting for other factors, the risk with oxycodone was nearly 80 percent higher than with transdermal fentanyl.8Southern Medical Journal. Incidence of Constipation Associated with Long-acting Opioid Therapy: A Comparative Study The real-world rate is almost certainly higher than what shows up in medical records.

How Oxycodone Compares to Other Opioids

All opioids can cause constipation because they all activate the same receptors in the gut. That said, some appear to carry a somewhat higher risk than others. A large retrospective study of people with non-cancer pain in England found that, compared to codeine, oxycodone was associated with about a 46 percent higher risk of severe constipation, while morphine carried about a 59 percent higher risk. Even fentanyl, often considered easier on the gut, carried a 37 percent higher risk than codeine.9PubMed Central. Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England

Interestingly, not all studies agree on the ranking. A study in hospice patients found no meaningful difference in constipation severity among people prescribed sustained-release morphine, oxycodone, or transdermal fentanyl.10Pain Medicine. Toward Evidence-Based Prescribing at End of Life: A Comparative Analysis of Sustained-Release Morphine, Oxycodone, and Transdermal Fentanyl, with Pain, Constipation, and Caregiver Interaction Outcomes in Hospice Patients The discrepancies likely reflect differences in populations, dosing, and how constipation was measured. The practical message is that switching from oxycodone to another opioid may or may not improve constipation, and you should not assume a different opioid will solve the problem entirely.

Older Adults Face a Steeper Risk

Age makes opioid-induced constipation worse. The gut naturally slows with age, many older adults take other medications that contribute to constipation, and fluid intake tends to drop. In one study comparing oxycodone controlled-release to transdermal fentanyl in a Medicaid population, patients aged 65 and older on oxycodone were more than seven times as likely to be constipated as those on transdermal fentanyl.11The Consultant Pharmacist. Risk of Constipation in Patients Prescribed Fentanyl Transdermal System or Oxycodone Hydrochloride Controlled-Release in a California Medicaid Population A separate study of male geriatric patients on oral oxycodone found that gastrointestinal problems were the most frequently reported adverse reaction, affecting a significant portion of the group.12PubMed. The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients

For older adults on long-term opioids, constipation is not just uncomfortable; it can lead to fecal impaction, bowel obstruction, and emergency department visits. A year-long study of geriatric patients using an oxycodone-naloxone combination found that pairing oxycodone with an opioid antagonist that stays in the gut could maintain pain relief while reducing constipation over 52 weeks.13PubMed Central. Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

Children and Young Adults Are Not Exempt

The gut mechanism does not care about age in the other direction either. Opioid-induced constipation is a recognized problem in children and adolescents, particularly those receiving opioids for cancer-related pain.14PubMed Central. Methylnaltrexone for Opioid-Induced Constipation in Children and Adolescents and Young Adults with Progressive Incurable Cancer at the End of Life Because younger patients may not articulate their symptoms clearly, caregivers and clinicians need to monitor bowel function proactively whenever oxycodone or another opioid is prescribed.

Managing the Constipation

Because tolerance does not develop to this side effect, managing it is not a short-term project. The standard approach works in layers, starting simple and escalating as needed.

General lifestyle measures form the first line: staying well hydrated, getting regular physical activity when possible, and eating enough dietary fiber.15PubMed Central. Opioid-induced constipation: a narrative review of therapeutic options in clinical management These help, but honestly, for many people on a meaningful dose of oxycodone, diet and exercise alone will not be enough.

Over-the-counter laxatives are the next step. Evidence from randomized trials suggests that common options like lactulose, polyethylene glycol (often sold as MiraLAX), and senna are roughly similar in effectiveness for opioid-induced constipation, with polyethylene glycol potentially being gentler on the stomach.16PubMed Central. Constipation in people prescribed opioids Many doctors start a laxative at the same time as the opioid prescription rather than waiting for constipation to develop, which is smart given how predictable the problem is.

When standard laxatives fall short, a class of drugs called peripherally acting mu-opioid receptor antagonists offers a more targeted solution. These medications block opioid receptors specifically in the gut without crossing into the brain, so they counteract constipation without interfering with pain relief.17PubMed Central. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety Examples available by prescription include naloxegol, methylnaltrexone, and naldemedine.

Another approach built on the same logic is a combination tablet of oxycodone with naloxone. Naloxone is an opioid antagonist, but when taken by mouth, it is mostly broken down by the liver before reaching the brain, so it blocks the drug’s action in the gut while leaving pain relief largely intact. Multiple large trials have shown that this combination improves bowel function scores compared to oxycodone alone.18PubMed. Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation Controlled studies in both non-cancer and cancer pain found that daily doses of up to 80 mg oxycodone paired with 40 mg naloxone provided equivalent pain control with less bowel disruption.19PubMed. Oxycodone/naloxone in the management of patients with pain and opioid-induced bowel dysfunction In an observational study of patients whose constipation had not responded to standard laxatives, about two-thirds reported improvement after switching to this combination, along with better overall quality of life.20PubMed Central. Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study

Abdominal Massage as an Adjunct

For people looking for a non-drug approach to layer on top of other measures, abdominal massage has some supporting evidence. A study of patients with opioid-induced constipation found that regular abdominal massage reduced constipation severity, decreased straining and bloating, improved stool consistency, increased the number of bowel movements, and improved quality of life scores.21PubMed. The efficacy of abdominal massage in managing opioid-induced constipation It is not a standalone fix, but as something you can do at home with no side effects, it is a reasonable addition to other treatments.

Oxycodone and Constipation After Surgery

Constipation from opioids takes on extra significance after abdominal surgery, where getting the gut moving again is a key milestone for recovery. Opioid pain relievers used after bowel surgery directly delay the return of normal gastrointestinal function, contributing to longer hospital stays and slower recovery.22PubMed. The opioid component of delayed gastrointestinal recovery after bowel resection

A randomized trial of patients undergoing laparoscopic colorectal surgery found that those given the oxycodone-naloxone combination had their first bowel movement roughly a day sooner than those given oxycodone alone.23BJS. Randomized open-label phase II study comparing oxycodone–naloxone with oxycodone in early return of gastrointestinal function after laparoscopic colorectal surgery A day might not sound like much, but in the post-surgical setting, earlier return of bowel function can mean earlier discharge and fewer complications. Surgical teams increasingly use opioid-sparing strategies for exactly this reason, combining lower opioid doses with non-opioid pain medications to reduce the gut effects.

Tracking Your Symptoms

If you are on oxycodone and unsure whether what you are experiencing counts as opioid-induced constipation, clinicians sometimes use a simple three-question tool called the Bowel Function Index. It asks about ease of defecation, the feeling of incomplete bowel emptying, and your personal judgment of how constipated you feel.24PubMed. The Bowel Function Index: a new validated scale for assessing opioid-induced constipation The score helps both you and your doctor decide whether your current management is working or whether it is time to add something.25PubMed. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation You do not need to suffer in silence or assume that some level of misery is just the price of pain relief.

The Financial Weight of the Problem

Opioid-induced constipation is not just a quality-of-life issue; it drives substantial healthcare costs. Among long-term opioid users with non-cancer pain, those who developed constipation had significantly more hospital admissions than matched patients without it. In non-elderly adults, the hospitalization rate was 33 percent for the constipation group versus 22 percent for those without, and the gap widened in elderly patients (51 percent versus 31 percent). Total healthcare costs were roughly double for the constipated group.26PubMed Central. Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain

A separate analysis found that opioid users with constipation were about twice as likely to be hospitalized as those without, and their total annual healthcare costs were more than $12,000 higher per person. Constipation-related costs alone averaged over $4,600 per year.27American Health & Drug Benefits. Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain These numbers reflect emergency visits, additional medications, diagnostic testing, and sometimes surgical intervention for severe complications like bowel obstruction. The problem is expensive enough that payers and health systems have a genuine financial incentive to prevent it, which is part of why interest in proactive laxative prescribing and opioid-antagonist combinations has grown.